Click the Why column to see why an item matched the search.
Match | Type | Why |
---|
Beck, Laurence | Person |
Why?
|
Salant, David | Person |
Why?
|
A conceptual framework linking immunology, pathology, and clinical features in primary membranous nephropathy. | Academic Article |
Why?
|
Anti-phospholipase A2 receptor antibodies and malignancy in membranous nephropathy. | Academic Article |
Why?
|
Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. | Academic Article |
Why?
|
Anti-phospholipase A2 receptor antibodies in recurrent membranous nephropathy. | Academic Article |
Why?
|
Anti-phospholipase A2 receptor antibody in membranous nephropathy. | Academic Article |
Why?
|
Antiphospholipase A2 receptor antibody-positive membranous nephropathy in the kidney donor: Lessons from a serendipitous transplantation. | Academic Article |
Why?
|
Authors'' Reply: In Silico-Based Approach to the Discovery of New Antigens in Membranous Nephropathy. | Academic Article |
Why?
|
Complement activation and effector pathways in membranous nephropathy. | Academic Article |
Why?
|
Complement mediates nephrin redistribution and actin dissociation in experimental membranous nephropathy. | Academic Article |
Why?
|
Deep pockets are not necessarily a good thing in membranous nephropathy: evidence for a modifier allele. | Academic Article |
Why?
|
Detection and monitoring PLA2R autoantibodies by LIPS in membranous nephropathy. | Academic Article |
Why?
|
Does Epitope Spreading Influence Responsiveness to Rituximab in PLA2R-Associated Membranous Nephropathy? | Academic Article |
Why?
|
Experimental membranous nephropathy redux. | Academic Article |
Why?
|